We are live on ! Find out more
PAS

Point72 Asia (Singapore) Portfolio holdings

AUM $646M
1-Year Est. Return 35.24%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+35.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$480M
AUM Growth
+$95.6M
Cap. Flow
+$90.5M
Cap. Flow %
18.85%
Top 10 Hldgs %
27.43%
Holding
1,618
New
585
Increased
129
Reduced
295
Closed
608

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.3M
2
RTX icon
RTX Corp
RTX
+$13.9M
3
AVGO icon
Broadcom
AVGO
+$12.3M
4
ICLR icon
Icon
ICLR
+$11.8M
5
TSM icon
TSMC
TSM
+$11.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.6M
2
DELL icon
Dell
DELL
+$6.39M
3
CRH icon
CRH
CRH
+$6.29M
4
META icon
Meta Platforms (Facebook)
META
+$5.61M
5
NFLX icon
Netflix
NFLX
+$4.68M

Sector Composition

Rank Sector Weight
1 Technology 24.04%
2 Industrials 19.65%
3 Financials 15.29%
4 Healthcare 12.3%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTB icon
576
Bank of N.T. Butterfield & Son
NTB
$2.44B
$67K 0.01%
1,908
-2,101
-52% -$70.4K
HUN icon
577
Huntsman Corp
HUN
$1.8B
$66.8K 0.01%
2,935
-357
-11% -$8.7K
SNEX icon
578
StoneX
SNEX
$7.72B
$65.8K 0.01%
2,950
-3,108
-51% -$66.3K
SSP icon
579
E.W. Scripps
SSP
$315M
$65.8K 0.01%
+20,943
New +$66.3K
CUE icon
580
Cue Biopharma
CUE
$106M
$65.8K 0.01%
+1,768
New +$87.4K
DOC icon
581
Healthpeak Properties
DOC
$14.5B
$65.6K 0.01%
+3,348
New +$63.9K
CEVA icon
582
CEVA Inc
CEVA
$921M
$65.3K 0.01%
+3,385
New +$68.6K
EGRX
583
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$65K 0.01%
+11,612
New +$50.6K
BIRD icon
584
Smartbird Inc
BIRD
$21.7M
$64.8K 0.01%
+6,485
New +$79.1K
DK icon
585
Delek US
DK
$3.73B
$64.3K 0.01%
2,598
-9,920
-79% -$274K
NEO icon
586
NeoGenomics
NEO
$2.13B
$64.3K 0.01%
4,636
-8,048
-63% -$114K
MRNS
587
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$64.2K 0.01%
+54,878
New +$137K
PPL
588
PPL Corp
PPL
$26.4B
$63.6K 0.01%
+2,299
New +$64.5K
VOXX
589
DELISTED
VOXX International Corporation Class A
VOXX
$63.3K 0.01%
+20,033
New +$107K
VOR icon
590
Vor Biopharma
VOR
$1.25B
$63.3K 0.01%
+3,163
New +$102K
HAFC icon
591
Hanmi Financial
HAFC
$934M
$63.1K 0.01%
3,773
+1,207
+47% +$18.8K
KZR
592
DELISTED
Kezar Life Sciences
KZR
$63.1K 0.01%
+10,511
New +$79.9K
FARO
593
DELISTED
Faro Technologies
FARO
$62.5K 0.01%
3,905
-11,026
-74% -$204K
WK icon
594
Workiva
WK
$3.62B
$62.5K 0.01%
856
-1,773
-67% -$140K
POST icon
595
Post Holdings
POST
$3.47B
$62.3K 0.01%
+598
New +$62.2K
M icon
596
Macy's
M
$6.71B
$61.9K 0.01%
+3,226
New +$61.6K
AOSL icon
597
Alpha and Omega Semiconductor
AOSL
$1.04B
$61.9K 0.01%
+1,656
New +$43.8K
ACET icon
598
Adicet Bio
ACET
$74.5M
$61.6K 0.01%
+3,181
New +$85.2K
DNMR
599
DELISTED
Danimer Scientific, Inc.
DNMR
$61.5K 0.01%
+2,549
New +$79.2K
FL
600
DELISTED
Foot Locker
FL
$61.5K 0.01%
+2,466
New +$58.7K

Similar funds

Point72 Asia (Singapore)'s Q2 2024 Portfolio in Review

As of Q2 2024, Point72 Asia (Singapore) held 1,618 positions worth $480M, up 25% from $384M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Point72 Asia (Singapore) deployed $90.5M of net new capital in Q2 2024, opening 585 new positions and adding to 129 existing holdings. Its largest new stake was RTX Corp: 133,989 shares worth $13.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $18.6M trimmed.

  • Point72 Asia (Singapore)'s largest Q2 2024 buy was RTX Corp: 133,989 shares worth $13.5M.
  • Point72 Asia (Singapore) added most to Apple in Q2 2024, an estimated $14.3M increase.
  • Point72 Asia (Singapore)'s biggest Q2 2024 reduction was NVIDIA, cutting an estimated $18.6M.
  • Point72 Asia (Singapore) fully exited CRH in Q2 2024, selling an estimated $6.29M.
  • Point72 Asia (Singapore)'s ten largest holdings make up 27% of its $480M portfolio in Q2 2024.
  • Point72 Asia (Singapore) opened 585 new positions and closed 608 in Q2 2024.
  • Point72 Asia (Singapore)'s portfolio value rose 25% quarter-over-quarter to $480M.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.